Following the Bacillus Calmette-Guérin shortage, the first patient with bladder cancer has been dosed with recombinant ...

The management and treatment of prostate cancer is evolving to address unmet patient needs, with advancements spanning from diagnosis ...

The Urology Care Foundation is Encouraging You to Be Proactive for National Kidney Month March is National Kidney Month! BALTIMORE, Feb. 28, 2025 (GLOBE NEWSWIRE) -- March is National Kidney Month, ...

Sexual function data support enzalutamide use in men with high-risk biochemically recurrent (BCR) prostate cancer.

Updated clinical & translational results: BOND-003 Cohort C- A phase 3, single-arm study of intravesical cretostimogene grenadenorepvec for high-risk BCG-unresponsive non-muscle invasive bladder ...

A live webcast of the event, as well as an archived recording, will be available on the “Investors” section of the Company’s website at https://ir.procept-biorobotics.com/. The webcast will be ...

Urology of Virginia, a globally recognized leader in urologic care, is reinventing patient education and clinic efficiency ...

U.S. Urology Partners is one of the first providers to offer patients ImmunityBio’s recombinant Bacillus Calmette-Guérin (rBCG) The FDA recently authorized ImmunityBio’s EAP for rBCG to address U.S.

Jefferson Regional Hospital’s Urology Associates will be participating in what’s being called a “March Madness Wellness Event ...